BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jan 21, 2024; 30(3): 211-224
Published online Jan 21, 2024. doi: 10.3748/wjg.v30.i3.211
Why is early detection of colon cancer still not possible in 2023?
Valeria Tonini, Manuel Zanni
Valeria Tonini, Manuel Zanni, Department of Medical and Surgical Sciences, University of Bologna, Bologna 40138, Italy
Author contributions: Tonini V and Zanni M contributed equally to this work; All authors read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that there are no conflicts of interest.
Corresponding author: Valeria Tonini, MD, PhD, Adjunct Associate Professor, Surgeon, Surgical Oncologist, Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, Bologna 40138, Italy. valeria.tonini@unibo.it
Received: August 31, 2023
Peer-review started: August 31, 2023
First decision: September 26, 2023
Revised: October 30, 2023
Accepted: December 14, 2023
Article in press: December 14, 2023
Published online: January 21, 2024
Processing time: 139 Days and 20.8 Hours
Core Tip

Core Tip: Colorectal cancer (CRC) screening is a fundamental tool in the prevention and early detection of a prevalent and lethal cancers. Despite advancements in screening, the effectiveness of CRC screening programs remains less than optimal. This paper examined the multifaceted reasons behind the persistent lack of effectiveness in CRC screening initiatives. This study aimed to raise awareness of how CRC screening can reduce costs. Screening and early detection improve the prognosis of patients with CRC and result in an important reduction in the cost of treating advanced disease. Spending more sooner can mean saving money later.